Genetically-engineered parasite could serve as malaria vaccine

| | September 19, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Malaria parasites weakened through precise gene deletions could be used as a vaccine to protect against malaria infection, according to a study recently published in Vaccine.

The study followed up on previous research that tested a new malaria vaccine with parasites weakened by radiation. The trial was promising but vaccination required intravenous administration with multiple high doses. Researchers at Seattle BioMed outlined a method to attenuate the malaria parasite through genetic engineering, which could offer a consistently protective malaria vaccine.

Read the full, original story here: Genetically-engineered parasite could serve as malaria vaccine

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend